|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 2
Zeitschriftenartikel
Ponde, Noam; Bradbury, Ian; Lambertini, Matteo; Ewer, Michael; Campbell, Christine; Ameels, Helene; Zardavas, Dimitrios; Di Cosimo, Serena; Baselga, Jose; Huober, Jens; Izquierdo, Miguel; Fumagalli, Debora; Bozovic-Spasojevic, Ivana; Maetens, Marion; Harbeck, Nadia; Pusztai, Lajos; Berghorn, Michael; Im, Young-Hyuck; Ruiz Borrego, Manuel; Chen, Dar-Ren; Rodeheffer, Richard; Piccart, Martine; Suter, Thomas und Azambuja, Evandro de
(2018):
Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a NeoALTTO sub-study (BIG 1-06).
In: Breast Cancer Research and Treatment, Bd. 168, Nr. 3: S. 631-638
Fasching, Peter A.; Jud, Sebastian M.; Hauschild, Maik; Kümmel, Sherko; Schütte, Martin; Warm, Matthias; Hanf, Volker; Grab, Dieter; Krocker, Jutta; Stickeler, Elmar; Kreienberg, Rolf; Müller, Thomas; Kühn, Thorsten; Wolf, Christopher; Kahlert, Steffen; Paepke, Stefan; Berghorn, Michael; Muth, Mathias; Baier, Monika; Wackwitz, Birgit; Schulz-Wendtland, Rüdiger; Beckmann, Matthias W. und Lux, Michael P.
(2014):
FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients.
In: BMC Cancer
14:66
[PDF, 425kB]